ENTX

NASDAQ · Biotechnology

Entera Bio Ltd

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$3.15

-0.07 (-2.17%)

ENTX News1 articles

Rani Therapeutics Soars 29%, Narrows Nasdaq Compliance Gap to 11%

Rani Therapeutics shares jumped 29.4% to $0.89, reducing the gap to Nasdaq's $1 minimum bid to about 11%. CEO Talat Imran's open-market purchase and promising Phase 1a results for RT-114 fueled the rally.